Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir.
Elion
Richard
R
Berger
Daniel
D
Richmond
Gary
G
Sension
Michael
M
Dejesus
Edwin
E
Cimoch
Paul
P
St Clair
Marty
M
Yau
Linda
L
Ha
Belinda
B
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000069446:Atazanavir Sulfate; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008077:Lipoproteins, LDL / Q000378:metabolism; D008297:Male; D054539:Medication Therapy Management; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D010865:Pilot Projects; D011725:Pyridines / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D016896:Treatment Outcome; D028761:Withholding Treatment; D000099227:Abacavir
D019380:Anti-HIV Agents; D000069446:Atazanavir Sulfate; D015224:Dideoxynucleosides; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D008077:Lipoproteins, LDL; D009842:Oligopeptides; D011725:Pyridines; D019438:Ritonavir; D000099227:Abacavir